SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-24-007490
Filing Date
2024-11-01
Accepted
2024-11-01 16:24:22
Documents
2
Period of Report
2024-11-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 6366
2 POA gshifermanpoa.txt EX-24 1813
  Complete submission text file 0001562180-24-007490.txt   9624
Mailing Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SAGE THERAPEUTICS, INC. 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142
Business Address
Shiferman Gregory L. (Reporting) CIK: 0002041689 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 241419395